Background Malignant pleural mesothelioma (MPM) is an aggressive and rare tumour with
poor prognosis. Most patients are diagnosed with advanced disease and there is a paucity …

Background Overall survival (OS) for malignant pleural mesothelioma (MPM) in vulnerable
subgroups remains poorly understood with scarce data available to guide treatment …

Purpose Malignant pleural mesothelioma (MPM) is an aggressive cancer with long latency
and poor prognosis. The real-world treatment patterns and humanistic burden of MPM in an …

Objectives Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer with a
poor prognosis and limited treatment options. This study assessed the characteristics …

Background Malignant pleural mesothelioma (MPM) is a rare, aggressive malignancy of the
pleural cavity linked to asbestos exposure. The combination of pemetrexed and platinum is …

Background This study aims to investigate patient-and disease characteristics associated
with survival in malignant pleural mesothelioma (MPM) patients with anti-tumor treatment or …

Background Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy
that most commonly affects the pleural layers. MPM has a strong association with asbestos …

Malignant Mesothelioma (MM) is an aggressive neoplasm of the pleural mesothelium, less
frequently peritoneal and exceptionally of the vaginal tunic of the testicle and pericardium …

Objectives Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer, for
which treatment is often limited to palliative combination chemotherapy. Multimodality …

Introduction Malignant pleural mesothelioma (MPM) is an aggressive malignancy that affects
older adults with frequent comorbidities, making real-world treatment decisions challenging …